UNII PQ6CK8PD0R

ASCORBIC ACID

Unique Ingredient Identifier PQ6CK8PD0R is listed as a ingredient substance
UniiPQ6CK8PD0R
Preferred Substance NameASCORBIC ACID
Rn50-81-7
Ec200-066-2
NcitC285
Rxcui1151
Pubchem54670067
Inn Id372
Molecular FormulaC6H8O6
InchikeyCIWBSHSKHKDKBQ-JLAZNSOCSA-N
Smiles[H][[email protected]@]1(OC(=O)C(O)=C1O)[[email protected]@H](O)CO
Unii TypeINGREDIENT SUBSTANCE
RN50-81-7
EC200-066-2
NCITC285
RXCUI1151
PUBCHEM54670067
INN ID372
MFC6H8O6
INCHI KEYCIWBSHSKHKDKBQ-JLAZNSOCSA-N
SMILESOC[[email protected]](O)[[email protected]]1OC(=O)C(O)=C1O

Alternate Names

Dosage Forms

UNII PQ6CK8PD0R ASCORBIC ACID is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,INFILTRATIONINJECTION NA
CAUDAL BLOCKINJECTION NA
EPIDURALINJECTION NA
IM - IVINJECTION0.2 %
INHALATIONAEROSOL, METERED959.5 MG/INH
INHALATIONAEROSOL, SPRAY0.11 %
INHALATIONSOLUTION1.02 %
INTRAMUSCULARINJECTION1 %
INTRAVENOUSINJECTION120 MG/ML
INTRAVENOUSINJECTION62.5 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION0.2 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.088 %
INTRAVENOUSSOLUTION, INJECTION0.2 %
IV(INFUSION)INJECTION50.4 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION NA
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED48 %
NERVE BLOCKINJECTION NA
NERVE BLOCKSOLUTION, INJECTION0.2 %
ORALCAPSULE7 MG
ORALCAPSULE, EXTENDED RELEASE0.4 MG
ORALCONCENTRATE6 MG/1ML
ORALPOWDER, FOR ORAL SOLUTION5 MG
ORALSOLUTION30 MG/5ML
ORALSUSPENSION50 MG/5ML
ORALSUSPENSION, EXTENDED RELEASE2.93 MG/5ML
ORALSUSPENSION, SUSTAINED ACTION NA
ORALSYRUP29.97 MG/5ML
ORALTABLET28.44 MG
ORALTABLET, FILM COATED20 MG
ORALTABLET, ORALLY DISINTEGRATING2.35 MG
RECTALSUPPOSITORY3 MG
SUBCUTANEOUSINJECTION1 %
TOPICALGEL0.3 %W/W
TOPICALSOLUTION0.044 %W/W

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.